Detalles de la búsqueda
1.
Oral 5-Day Lefamulin for Outpatient Management of Community-Acquired Bacterial Pneumonia: Post-hoc Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 2 Trial.
J Emerg Med
; 60(6): 781-792, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33731270
2.
A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema.
Pediatr Allergy Immunol
; 30(5): 553-561, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30968444
3.
Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial.
JAMA
; 322(17): 1661-1671, 2019 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31560372
4.
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial.
JAMA
; 320(20): 2108-2121, 2018 11 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30480729
5.
Preventing Hereditary Angioedema Attacks in Children Using Cinryze®: Interim Efficacy and Safety Phase 3 Findings.
Int Arch Allergy Immunol
; 173(2): 114-119, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28662509
6.
Health-related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidase.
Allergy Asthma Proc
; 38(2): 143-151, 2017 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28093999
7.
Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema.
Allergy Asthma Proc
; 37(6): 489-500, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27931305
8.
Reply to Tang and Lai.
Clin Infect Dis
; 71(6): 1583, 2020 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31822883
9.
Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema.
Pediatr Allergy Immunol
; 26(7): 674-80, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26171584
10.
Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromycin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia.
Antimicrob Agents Chemother
; 57(6): 2526-34, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23507282
11.
Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacin.
J Glob Antimicrob Resist
; 29: 434-443, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34788694
12.
Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects.
Antimicrob Agents Chemother
; 55(5): 1997-2003, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21282444
13.
A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant S. pneumoniae in Ambulatory and Hospitalized Adult Patients in the United States.
Open Forum Infect Dis
; 8(7): ofab063, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34250183
14.
Anidulafungin versus fluconazole for invasive candidiasis.
N Engl J Med
; 356(24): 2472-82, 2007 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-17568028
15.
The 1-year economic burden of community-acquired pneumonia (CAP) initially managed in the outpatient setting in the USA.
J Comp Eff Res
; 9(2): 127-140, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31840552
16.
The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study.
Curr Med Res Opin
; 36(1): 151-160, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31566005
17.
Health-Related Quality of Life as Measured by the 12-Item Short-Form Survey Among Adults With Community-Acquired Bacterial Pneumonia who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials.
Open Forum Infect Dis
; 7(6): ofaa209, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32617376
18.
Post Hoc Assessment of Time to Clinical Response Among Adults Hospitalized with Community-Acquired Bacterial Pneumonia Who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials.
Open Forum Infect Dis
; 7(5): ofaa145, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32462049
19.
Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized Study.
J Allergy Clin Immunol Pract
; 7(5): 1610-1618.e4, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30682573
20.
Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Upper Airway Angioedema.
J Allergy Clin Immunol Pract
; 5(5): 1402-1409.e3, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28552382